{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:49:43Z","timestamp":1774396183614,"version":"3.50.1"},"reference-count":54,"publisher":"EDITORA SCIENTIFIC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Bras. Psiquiatr."],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1590\/1516-4446-2014-1387","type":"journal-article","created":{"date-parts":[[2015,3,21]],"date-time":"2015-03-21T19:58:43Z","timestamp":1426967923000},"page":"71-79","source":"Crossref","is-referenced-by-count":16,"title":["Structural and functional neuroimaging findings associated with the use of clozapine in schizophrenia: a systematic review"],"prefix":"10.47626","volume":"37","author":[{"given":"Giovana J.","family":"Garcia","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos H.","family":"Chagas","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos H.","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o P.","family":"Machado-de-Sousa","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP), Brazil; Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Crippa","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP), Brazil; Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime E.","family":"Hallak","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP), Brazil; Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27448","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia","volume":"363","author":"Mueser KT","year":"2004","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel TR","year":"2010","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, \u201cjust the facts\u201d 4. Clinical features and conceptualization","volume":"110","author":"Tandon R","year":"2009","journal-title":"Schizophr Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2008.01.022","article-title":"Schizophrenia, \u201cJust the Facts\u201d: what we know in 2008 part 1: overview","volume":"100","author":"Tandon R","year":"2008","journal-title":"Schizophr Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.neuro.25.112701.142754","article-title":"Schizophrenia as a disorder of neurodevelopment","volume":"25","author":"Lewis DA","year":"2002","journal-title":"Annu Rev Neurosci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/npp.1993.46","article-title":"Schizophrenia: a neurodevelopmental perspective","volume":"9","author":"Pilowsky LS","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0140-6736(93)90288-R","article-title":"Schizophrenia: developmental neuroscience and pathobiology","volume":"341","author":"Waddington JL","year":"1993","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/schbul\/19.2.287","article-title":"Psychopharmacologic treatment of schizophrenia","volume":"19","author":"Kane JM","year":"1993","journal-title":"Schizophr Bull"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/schbul\/21.4.579","article-title":"Clozapine: efficacy and safety","volume":"21","author":"Buchanan RW","year":"1995","journal-title":"Schizophr Bull"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT)","volume":"60","author":"Meltzer HY","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1176\/ajp.156.7.990","article-title":"Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials","volume":"156","author":"Wahlbeck K","year":"1999","journal-title":"Am J Psychiatry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4088\/JCP.10r06264yel","article-title":"Past and present progress in the pharmacologic treatment of schizophrenia","volume":"71","author":"Kane JM","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"(8)","key":"ref13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0165-6147(00)01507-8","article-title":"Pharmacological magnetic resonance imaging: a new application for functional MRI","volume":"21","author":"Leslie RA","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(95)90441-7","article-title":"Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine","volume":"345","author":"Chakos M","year":"1995","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/ajp.153.4.564","article-title":"Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment","volume":"153","author":"Frazier JA","year":"1996","journal-title":"Am J Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0893-133X(00)00172-X","article-title":"The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics","volume":"24","author":"Scheepers FE","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1176\/appi.ajp.158.4.644","article-title":"Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia","volume":"158","author":"Scheepers FE","year":"2001","journal-title":"Am J Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.schres.2005.07.031","article-title":"Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia","volume":"80","author":"Molina V","year":"2005","journal-title":"Schizophr Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/sj.npp.1301347","article-title":"Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study","volume":"32","author":"van Haren NE","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.schres.2009.10.018","article-title":"Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia","volume":"116","author":"Mattai A","year":"2010","journal-title":"Schizophr Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0730-725X(94)91227-N","article-title":"Functional magnetic resonance imaging at 1.5 T: activation pattern in schizophrenic patients receiving neuroleptic medication","volume":"12","author":"Wenz F","year":"1994","journal-title":"Magn Reson Imaging"},{"key":"ref22","first-page":"89","article-title":"Parieto-prefrontal dysfunction during visuo-auditory information processing in elderly, chronic schizophrenic patients and medication effects","volume":"36","author":"Schmitt A","year":"2009","journal-title":"Rev Psiquiatr Clin"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0925-4927(01)00102-0","article-title":"Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia","volume":"107","author":"Bustillo JR","year":"2001","journal-title":"Psychiatry Res"},{"key":"ref24","first-page":"17","article-title":"N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study","volume":"13","author":"Szulc A","year":"2007","journal-title":"Med Sci Monit"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pscychresns.2009.04.007","article-title":"The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: relationship with treatment response","volume":"174","author":"Ertugrul A","year":"2009","journal-title":"Psychiatry Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0925-4927(97)00057-7","article-title":"Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study","volume":"76","author":"Rodriguez VM","year":"1997","journal-title":"Psychiatry Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2190\/1AA0-UW9Q-1CNK-3E2N","article-title":"The effects of clozapine on cognitive function and regional cerebral blood flow in the negative symptom profile schizophrenia","volume":"36","author":"Zhao J","year":"2006","journal-title":"Int J Psychiatry Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.pnpbp.2007.12.028","article-title":"Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients","volume":"32","author":"Molina V","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref29","first-page":"35","article-title":"Evaluation of SISCOM in routine regional cerebral blood flow alterations after clozapine, in schizophrenia","volume":"13","author":"Ergun EL","year":"2010","journal-title":"Hell J Nucl Med"},{"key":"ref30","first-page":"155","article-title":"Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia","volume":"6","author":"Buchsbaum MS","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.1997.01830170107014","article-title":"The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task","volume":"54","author":"Cohen RM","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0893-133X(99)00065-2","article-title":"The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia: evidence of a sex effect","volume":"21","author":"Cohen RM","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0006-3223(02)01602-5","article-title":"Functional effects of antipsychotic drugs: comparing clozapine with haloperidol","volume":"53","author":"Lahti AC","year":"2003","journal-title":"Biol Psychiatry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.npp.1300312","article-title":"Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex","volume":"29","author":"Lahti AC","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-004-1981-9","article-title":"Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement","volume":"178","author":"Molina V","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2007-984399","article-title":"Marked hypofrontality in clozapine-responsive patients","volume":"40","author":"Molina V","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0024-3205(99)00106-X","article-title":"Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum","volume":"64","author":"Lee H","year":"1999","journal-title":"Life Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/ajp.153.1.41","article-title":"Functional sites of neuroleptic drug action in the human brain: PET\/FDG studies with and without haloperidol","volume":"153","author":"Holcomb HH","year":"1996","journal-title":"Am J Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/sj.npp.1300449","article-title":"Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat","volume":"29","author":"Wang HD","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"Lieberman JA","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"ref41","first-page":"8","article-title":"Brain region effects of clozapine on amino acid and monoamine transmission","volume":"55","author":"Yamamoto BK","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0022-3565(24)37401-4","article-title":"Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat","volume":"285","author":"Grobin AC","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF00449814","article-title":"Clozapine: new research on efficacy and mechanism of action","volume":"238","author":"Meltzer HY","year":"1989","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.schres.2005.05.009","article-title":"Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia","volume":"78","author":"Davis CE","year":"2005","journal-title":"Schizophr Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(24)37013-2","article-title":"Clozapine and haloperidol modulate N-methyl-D-aspartate-and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro","volume":"283","author":"Arvanov VL","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.mp.4001193","article-title":"Clozapine-induced reduction of glutamate transport in the frontal cortex is not mediated by GLAST and EAAC1","volume":"8","author":"Melone M","year":"2003","journal-title":"Mol Psychiatry"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.npp.1300850","article-title":"Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis","volume":"30","author":"Steen RG","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1017\/S0033291709005315","article-title":"Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings","volume":"39","author":"Navari S","year":"2009","journal-title":"Psychol Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.npp.1300603","article-title":"Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study","volume":"30","author":"Dazzan P","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1176\/ajp.156.8.1200","article-title":"Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics","volume":"156","author":"Corson PW","year":"1999","journal-title":"Am J Psychiatry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0920-9964(99)00089-4","article-title":"Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia","volume":"41","author":"Ende G","year":"2000","journal-title":"Schizophr Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0925-4927(98)00034-1","article-title":"Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect","volume":"83","author":"Heimberg C","year":"1998","journal-title":"Psychiatry Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.96.23.13432","article-title":"Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia","volume":"96","author":"Honey GD","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0006-3223(00)01001-5","article-title":"Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia","volume":"49","author":"Miller DD","year":"2001","journal-title":"Biol Psychiatry"}],"container-title":["Revista Brasileira de Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbp\/v37n1\/1516-4446-rbp-2015-37-1-71.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T09:17:12Z","timestamp":1747819032000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462015000100071&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1516-44462015000100071"],"URL":"https:\/\/doi.org\/10.1590\/1516-4446-2014-1387","relation":{},"ISSN":["1516-4446"],"issn-type":[{"value":"1516-4446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}